Plain-English translation of NCT05215535 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Doctors need to know whether rectal cancer has spread to the liver before planning treatment. This trial is testing whether a special type of imaging scan called MRI is better than the standard CT scan at finding liver cancer spread. The study will help doctors choose the best scan for patients like you.
Research shows that MRI may be more accurate than CT at detecting cancer spread to the liver, but many hospitals still use CT as standard care. This trial will confirm whether switching to MRI would help doctors catch more cases of cancer spread and improve treatment planning.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either an MRI scan or a CT scan of your abdomen and liver as part of your regular cancer evaluation. Both scans are non-invasive and painless imaging tests that take about 15–30 minutes. Your doctors will use the scan results to help plan your rectal cancer treatment, just as they would with standard care.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Sweden
Sponsor
Vastra Gotaland Region
Enrollment target
~400 participants
Started
April 2022
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jennifer Park, MD, PhD
Sahlgrenska University Hospital, Sahlgrenska Academy, Gothenburg Sweden
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.